Nephrology
Update | Management of hepatorenal syndrome in liver cirrhosis.
19 Sep, 2022 | 12:27h | UTC
Cohort Study | Patients diagnosed with diabetes by oral glucose tolerance test without elevated HbA1c had similar cardiovascular and renal disease risks as those without diabetes.
15 Sep, 2022 | 13:12h | UTC
Commentary on Twitter
#OriginalResearch: Oral glucose tolerance test diagnosed #diabetes were not confirmed by HbA1c during 4 year follow-up. Cases without HbA1c confirmation had similar vascular risk as the diabetes-free population. @whitehall2study @MikaKivimaki #AHAJournals https://t.co/ujC8cjRS7S pic.twitter.com/CRR3zlm5x2
— Circulation (@CircAHA) August 30, 2022
Review | Postoperative acute kidney injury.
15 Sep, 2022 | 13:00h | UTCPostoperative AKI – Clinical Journal of the American Society of Nephrology
Systematic Review | Hypoxia‐inducible factor stabilizers for the anemia of chronic kidney disease.
8 Sep, 2022 | 14:35h | UTCHypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease – Cochrane Library
Brief Review | Monitoring of renal perfusion.
5 Sep, 2022 | 14:27h | UTCMonitoring of renal perfusion – Intensive Care Medicine
Commentary on Twitter
Hypoperfusion long considered among main predisposing factors for #AKI in #ICU; this recently challenged ie #sepsis. How to monitor renal perfusion?
🫘 RI doppler-based renal resistive index/RI change
🫘 CEUS
🫘 RVI renal venous impedance index#FOAMcc
🖇️ https://t.co/Eejruztegw pic.twitter.com/KLCksRjx6U— Intensive Care Medicine (@yourICM) September 3, 2022
M-A | The impact of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury on mortality and clinical outcomes.
1 Sep, 2022 | 11:33h | UTCRelated:
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial – The Lancet (link to abstract – $ for full-text)
Review/Perspective | European hypertension guideline downgrading of beta-blockers is not justified.
31 Aug, 2022 | 11:51h | UTC
Guideline | Management of kidney transplant patients with HLA antibodies.
31 Aug, 2022 | 11:47h | UTC
Salt substitutes vs. regular salt: a quick look.
30 Aug, 2022 | 12:02h | UTCSalt substitutes vs. regular salt: a quick look – Evidently Cochrane
Original Study: Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women – Cochrane Library
Related:
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart (link to abstract – $ for full-text)
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Commentary on Twitter
https://twitter.com/CochraneLibrary/status/1563130897159028737
Cohort Study | Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis.
30 Aug, 2022 | 11:53h | UTC
Commentary on Twitter
https://twitter.com/JAMANetworkOpen/status/1562922771730305030
[News release – not published yet] #ESCCongres – RCT | Evening dosing of blood pressure medication not better than morning dosing.
29 Aug, 2022 | 12:30h | UTCRelated Consensus Statement: Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension – Journal of Hypertension
Related study (conflicting results): Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial
Bedtime dosing of antihypertensive medications: systematic review and consensus statement. – “use of bedtime drug dosing of antihypertensive drugs should not be routinely recommended”.
29 Aug, 2022 | 12:28h | UTC
RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
29 Aug, 2022 | 12:25h | UTCAcetazolamide in Acute Decompensated Heart Failure with Volume Overload – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Acetazolamide improves decongestion in patients with acute decompensated heart failure – European Society of Cardiology
Commentary: Acetazolamide in Decompensated Heart Failure With Volume Overload – ADVOR – American College of Cardiology
Commentary on Twitter
https://twitter.com/NEJM/status/1563421082505588738
RCT | Efficacy of potassium supplementation on the risk of peritonitis in hypokalemic patients receiving peritoneal dialysis.
26 Aug, 2022 | 13:25h | UTCEfficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial – American Journal of Kidney Diseases (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/AJKDonline/status/1528677142036455425
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.
26 Aug, 2022 | 13:08h | UTCOriginal Study: Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury – New England Journal of Medicine
Related:
Brief Review | New drugs for acute kidney injury.
25 Aug, 2022 | 11:58h | UTCNew drugs for acute kidney injury – Intensive Care Medicine
Review | Subphenotypes in acute kidney injury.
25 Aug, 2022 | 11:50h | UTCSubphenotypes in acute kidney injury: a narrative review – Critical Care
Position Statement | Chronic kidney disease as cardiovascular risk factor in routine clinical practice.
24 Aug, 2022 | 14:14h | UTC
Guideline | Management of adults with diabetes on dialysis.
23 Aug, 2022 | 13:16h | UTCManagement of adults with diabetes on dialysis – Joint British Diabetes Societies for Inpatient Care (PDF)
News Release: Latest JBDS dialysis guideline published – Diabetes Times
Observational analysis shows chronic kidney disease is associated with increased risk of intracerebral hemorrhage.
23 Aug, 2022 | 13:12h | UTCAssociation of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage – JAMA Neurology (link to abstract – $ for full-text)
Review | Drug regimens of novel antibiotics in critically ill patients with varying renal functions.
23 Aug, 2022 | 12:49h | UTC
AHA Scientific Statement | Cardiovascular effects of home dialysis therapies.
22 Aug, 2022 | 12:24h | UTCTop Things to Know: CV Effects of Home Dialysis Therapies – American Heart Association
Commentaries:
AHA Urges More Home-Based Dialysis in Advanced Kidney Failure – TCTMD
Commentary on Twitter (thread – click for more)
https://twitter.com/bourneauguste/status/1559172680087228416
Review | Hemoperfusion in the intensive care unit.
22 Aug, 2022 | 11:56h | UTCHemoperfusion in the intensive care unit – Intensive Care Medicine
Cohort Study | Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease.
19 Aug, 2022 | 16:09h | UTCOriginal Study: Aldosterone in chronic kidney disease and renal outcomes – European Heart Journal
Editorial: Aldosterone excess and cardiorenal risk: more common than appreciated – European Heart Journal
Commentary on Twitter
https://twitter.com/ESC_Journals/status/1556898902258991104
M-A | Performance of confirmatory tests for diagnosing primary aldosteronism.
18 Aug, 2022 | 12:54h | UTC
Commentary on Twitter
https://twitter.com/HyperAHA/status/1559624529869160448